# Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product

> **NCT04422028** · PHASE1 · COMPLETED · sponsor: **Laboratorios Andromaco S.A.** · enrollment: 30 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Desogestrel 0.075 MG
- **DRUG:** Desogestrel 0.075 MG

## Key facts

- **NCT ID:** NCT04422028
- **Lead sponsor:** Laboratorios Andromaco S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-11
- **Primary completion:** 2020-01-11
- **Final completion:** 2020-01-28
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04422028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04422028, "Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04422028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*